Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BSA-Oleate Monounsaturated Fatty Acid Complex (5 mM) is composed of oleic acid (Item Nos. 90260 | 24659) and fatty acid-free bovine serum albumin (BSA) at an approximately 6:1 molar ratio of oleate:BSA. It was prepared under sterile conditions, then filtered and aliquoted into sterile vials. Cayman's BSA-Oleate Monounsaturated Fatty Acid Complex (5 mM) can be used for efficient fatty acid delivery to cells in culture for the purpose of monitoring lipid metabolism and inflammatory signaling pathways.1 It has been used in the study of lipid accumulation in hepatic steatosis.2,3 Cayman’s BSA-Oleate Monounsaturated Fatty Acid Complex (5 mM) is suitable for use in short- and long-term cell culture applications (25+ hours). For best results, it is recommended that this product be used in conjunction with Cayman’s BSA Control for BSA-Fatty Acid Complexes (5 mM) (Item No. 29556), prepared with fatty acid-free BSA. A BSA-oleate complex is also available as part of Cayman’s BSA-Oleate Reagent Set (5 mM) (Item No. 44712).
WARNING This product is not for human or veterinary use.
1. Cell culture models of fatty acid overload: Problems and solutions. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863(2), 143-151 (2018).
2. Development, expansion, and histological characterization of patient-
3. A microvascularized in vitro liver model for disease modeling and drug discovery. Biofabrication 17(1), (2024).
A retinoic acid: YAP1 signaling axis controls atrial lineage commitment. Cell Rep. 44(5), 115687 (2025).
Fatty acid desaturases link cell metabolism pathways to promote proliferation of Epstein-
Lipolysis-
Cinnabarinic acid protects against metabolic dysfunction-
Perturbation of de novo lipogenesis hinders MERS-
Transcriptional and metabolic changes following repeated fasting and refeeding of adipose stem cells highlight adipose tissue resilience. Nutrients 16(24), 4310 (2024).
VPS4A is the selective receptor for lipophagy in mice and humans. Mol. Cell. 84(22), 4436-4453.e4438 (2024).
CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-
Spartin-
Membrane lipid nanodomains modulate HCN pacemaker channels in nociceptor DRG neurons. Nat. Commun. 15(1), 9898 (2024).
A metabolic dysfunction-
Transcriptomic, epigenomic, and spatial metabolomic cell profiling redefines regional human kidney anatomy. Cell Metab. 36(5), 1105-1125 (2024).
A fluorogenic complementation tool kit for interrogating lipid droplet-
Arachidonic acid mobilization and peroxidation promote microglial dysfunction in Aβ pathology. J. Neurosci. 44(31), e0202242024 (2024).
The dynamic clustering of insulin receptor underlies its signaling and is disrupted in insulin resistance. Nat. Commun. 13(1), 7522 (2022).
Comprehensive single-
Characterizing brain metabolic function ex vivo with acute mouse slice punches. STAR Protoc. 2(2), 100559 (2021).